Patent Dental Implant System

Histology by Dr Peter Schüpbach of a Patent Implant (left) after four weeks of healing: no plaque migration beyond the soft-tissue level is visible, owing to the strong bond (centre) with the transmucosal Patent surface. (Image: Dr Peter Schüpbach)

The world’s first demonstrated bond between peri-implant soft tissue and a transmucosal synthetic surface has been achieved with the Patent Dental Implant System.

Histological investigations by a Swiss research group have shown that epithelial cells begin to attach to the transmucosal Patent surface already in the early stages of healing, creating a strong soft-tissue bond. This process is attributed to the surface’s mucophilic and cell-occlusive properties. The findings were presented in May during a scientific session at EuroPerio11 in Vienna in Austria but have not yet been published.

Unique to Patent Implants, this novel cell bond acts as a dynamic defence barrier, protecting peri-implant tissue against bacterial invasion, inflammation and disease progression.

No peri-implantitis in long-term studies

The efficacy of this soft-tissue bond has been validated in long-term studies of up to 12 years. In research by Brunello et al. in 2022 and Karapataki et al. in 2023, Patent implants showed no peri-implantitis—even in high-risk patients with periodontitis, poor oral hygiene or smoking habits.

More information can be found at www.mypatent.com.

Patent Peri-implantitis Dental implantology EAO congress EuroPerio